Evidence map›Paper›PMID 40113916›Full record

ArticleScientific reports2025

Prevalence and distribution of Plasmodium falciparum multidrug resistant 1 D1246Y allele among children in Ibadan Southwest, Nigeria.

Osazuwa John Patrick, Olukemi Kehinde Amodu, Adewale Allen Sokan-Adeaga, Micheal Ayodeji Sokan-Adeaga, Yasuhiro Kotera

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Molecular Surveillance ofPathogens (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Osazuwa John PatrickInstitute of Child Health, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria. mercypoj@gmail.com.ORCID http://orcid.org/0009-0004-1203-6147
Olukemi Kehinde AmoduInstitute of Child Health, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID http://orcid.org/0000-0003-1477-4229
Adewale Allen Sokan-AdeagaPublic Health Program, College of Health Sciences, Bowen University, Iwo, Nigeria.ORCID http://orcid.org/0000-0002-0885-1526
Micheal Ayodeji Sokan-AdeagaDepartment of Community Health and Primary Care, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.ORCID http://orcid.org/0000-0001-8550-1960
Yasuhiro KoteraFaculty of Medicine and Health Sciences, University of Nottingham, Nottingham, NG7 2TU, UK.ORCID http://orcid.org/0000-0002-0251-0085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and spread of the Plasmodium falciparum multidrug-resistant 1 (Pfmdr1) allele pose a significant setback to global efforts to control and eradicate malaria infection by diminishing the efficacy of commonly prescribed antimalarial drugs, particularly in Sub-Saharan Africa, where malaria remains endemic. The Pfmdr1 D1246Y mutation is of specific importance due to its potential role in modulating parasite susceptibility to antimalarial medicines and treatment outcomes. This study aimed to determine the presence and prevalence of the wild-type and mutant D1246Y alleles of Pfmdr1 among children in Ibadan, Southwest Nigeria. A total of 133 archived DNA samples collected between March 2016 and June 2021 from children aged 6 to 132 months with varying malaria phenotypes (asymptomatic infection, uncomplicated, and severe malaria) were analyzed. The Pfmdr1 D1246Y allele was amplified via nested PCR, and the mutation was detected using the restriction enzyme EcoRV. The digested nested PCR products were resolved on a 2% agarose gel and visualized under ultraviolet light. All statistical analyses were performed using SPSS version 25, and statistical significance was set at p ≤ 0.05. Among the 133 samples, 97 (72.9%) were successfully genotyped. Of these, 50 (51.55%) carried the wild-type allele, while 47 (48.45%) had the mutant allele. Notably, the Pfmdr1-1246Y mutation was detected in all severe malaria cases (41/41, 100%), whereas its prevalence was significantly lower in asymptomatic (3/36, 8.3%) and uncomplicated malaria cases (3/20, 15%). The difference in mutation prevalence across the malaria phenotypes was statistically significant (p < 0.05). The study provided valuable insight into the coexistence of wild-type and mutant Pfmdr1 D1246Y alleles within the population. It revealed a significantly higher mutation rate in all severe malaria cases, while the wild-type allele remained more prevalent overall. These findings contribute to a deeper understanding of the possible role of the wild-type and mutant D1246Y alleles in the various clinical manifestations of malaria.

Indexed as

ATP-Binding Cassette, Sub-Family C ProteinsMalaria, FalciparumPlasmodium falciparumAllelesAntimalarialsChildChild, PreschoolFemaleHumansInfantMaleMutationNigeriaPrevalenceAntimalarialsATP-Binding Cassette, Sub-Family C ProteinsMdr1 protein, Plasmodium falciparumMalariaMultidrug resistanceMutantPfmdr1-D1246Y allelePlasmodium falciparumWild-type

Identifiers

PMID40113916
PMCPMC11926228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.